Assessing Biomarkers in the Eye for Better Clinical Outcomes
Zilia is developing a groundbreaking technology bound to redefine the way we prevent, diagnose, and treat various ocular, neurological, and systemic conditions.Zilia’s technology provides health care professionals with new key clinical insight.
Why the Eye?
The eye is a unique window into a person’s health. Due to its relationship to the brain and the vascular system, the eye is an ideal setting to non-invasively monitor biomarkers related to ocular, neurological, and systemic diseases.
Assessment of Biomarkers in the Eye
We are developing a disruptive technology using imaging, spectrometry, and AI to identify and quantify biomarkers in the eye.
Measuring Oxygen Saturation in the Eye
Zilia Ocular is the first retinal camera to provide continuous measurements of oxygenation in the human eye.
What if we Could Prevent Vision Loss?
As oxygenation of the eye is a crucial biomarker in the leading causes of vision loss, such as glaucoma, diabetic retinopathy, and age-related macular degeneration, Zilia’s first product is bound to revolutionize the prevention, diagnosis, and treatment.
Our Partners
